|
|
|
Volumn 36, Issue 4 SUPPL. 8, 1999, Pages 16-25
|
|
New developments in the treatment of acute myeloid leukemia: Focus on topotecan
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 [3 (4 DIPHENYLACETYL 1 PIPERAZINYL) 2 HYDROXYPROPOXY]QUINOLINE;
5 AZA 2' DEOXYCYTIDINE;
AMSACRINE;
ANTINEOPLASTIC AGENT;
CISPLATIN;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
CYTARABINE;
DAUNORUBICIN;
DNA TOPOISOMERASE INHIBITOR;
ETOPOSIDE;
FLUDARABINE;
FUMAGILLOL CHLOROACETYLCARBAMATE;
GRANULOCYTE COLONY STIMULATING FACTOR;
HOMOHARRINGTONINE;
IDARUBICIN;
LISOFYLLINE;
RETINOIC ACID;
TAMOXIFEN;
THALIDOMIDE;
TOPOTECAN;
VINCRISTINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LEUKEMIA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG INDUCED DISEASE;
GENE THERAPY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MULTIDRUG RESISTANCE;
NEUTROPENIA;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ACUTE DISEASE;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
DNA TOPOISOMERASES, TYPE I;
HUMANS;
LEUKEMIA, MYELOID;
PROGNOSIS;
TOPOTECAN;
|
|
EID: 0033450760
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (14)
|
|
References (75)
|
